OA
MEDP icon

Oxbow Advisors’s Medpace MEDP Stock Holding History

Oxbow Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.42M Buy
9,201
+3
+0% +$1.54K 0.38% 70
2025
Q4 		$5.17M Sell
9,198
-79
-0.9% -$44.8K 0.45% 64
2025
Q3 		$4.77M Buy
9,277
+89
+1% +$38.9K 0.44% 62
2025
Q2 		$2.88M Buy
9,188
+323
+4% +$97K 0.32% 78
2025
Q1 		$2.7M Buy
+8,865
New +$2.98M 0.29% 74

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Oxbow Advisors's MEDP Position: Q1 2026 in Review

Oxbow Advisors increased its Medpace (MEDP) stake by 0.03% in Q1 2026, buying an estimated $1.54K and bringing the position to 9,201 shares worth $4.42M. The position accounts for 0.38% of the portfolio, ranked #70.

Oxbow Advisors first reported a position in MEDP in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.17M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Oxbow Advisors held 9,201 shares of Medpace worth $4.42M as of Q1 2026.
  • Oxbow Advisors bought 3 Medpace shares in Q1 2026, an estimated $1.54K.
  • Medpace made up 0.38% of Oxbow Advisors's portfolio in Q1 2026, its #70 holding.
  • Oxbow Advisors first reported a position in Medpace in Q1 2025 and has held it in 5 quarters since.
  • Oxbow Advisors's Medpace position peaked at $5.17M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Oxbow Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.